₹ 4.1 Cr
Volume transacted
26.5 K
stocks traded
Last Updated time: 18 Sep 9.00 AM
Natco Pharma Ltd
NSE: NATCOPHARM
YEARLOW
₹ 725
Last updated: 18 Sep 24
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
No data available
* All values are consolidated
Last Updated time:
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price | Day Open | Day High | Day Low |
---|
18 Sep 2024 | 1540.25 | 1560 | 1566.75 | 1520.05 |
17 Sep 2024 | 1561.55 | 1577 | 1583.85 | 1557.5 |
16 Sep 2024 | 1577 | 1585.85 | 1595 | 1557.9 |
13 Sep 2024 | 1582.9 | 1609.55 | 1618.35 | 1573 |
12 Sep 2024 | 1592.6 | 1596.3 | 1638.35 | 1565.65 |
11 Sep 2024 | 1592 | 1546.15 | 1622.6 | 1546.15 |
10 Sep 2024 | 1545.5 | 1564.45 | 1585 | 1535.45 |
09 Sep 2024 | 1545.75 | 1560.05 | 1561.55 | 1524.45 |
06 Sep 2024 | 1560 | 1560.2 | 1577.85 | 1532.35 |
05 Sep 2024 | 1554.2 | 1572.75 | 1598 | 1551 |
Date | Price |
---|---|
18 Sep 2024 | 1540.25 |
17 Sep 2024 | 1561.55 |
16 Sep 2024 | 1577 |
13 Sep 2024 | 1582.9 |
12 Sep 2024 | 1592.6 |
11 Sep 2024 | 1592 |
10 Sep 2024 | 1545.5 |
09 Sep 2024 | 1545.75 |
06 Sep 2024 | 1560 |
05 Sep 2024 | 1554.2 |
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Natco Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Natco Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Natco Pharma invests USD 8 mn in bio-tech firm eGenesis
Natco Pharma announced that its wholly owned Canadian subsidiary, Natco Pharma (Canada) In...
Read more
04 Sep 202412:07
Natco Pharma Canada arm invests $8 mln in eGenesis
eGenesis is engaged in using its multiplex gene editing and genome engineering platform to...
Read more
04 Sep 202412:01
Natco Pharma Ltd spurts 1.25%, up for third straight session
Natco Pharma Ltd rose for a third straight session today. The stock is quoting at Rs 1570....
Read more
23 Aug 202413:05
Natco Pharma schedules AGM
Natco Pharma announced that the 41th Annual General Meeting (AGM) of the company will be h...
Read more
12 Aug 202416:48
Board of Natco Pharma recommends dividend
Natco Pharma announced that the Board of Directors of the Company at its meeting held on 1...
Read more
12 Aug 202415:57
Natco Pharma spurts as Q1 PAT climbs 59% YoY to Rs 668 cr
Revenue from operations was at Rs 1,362.6 crore in Q1 FY25, up 19.47% from Rs 1140.5 crore...
Read more
12 Aug 202415:13
FAQs for 52 Week Low of Natco Pharma Ltd
Why is it important to track the 52-week low of Natco Pharma Ltd stocks?
What factors can lead to Natco Pharma Ltd stocks hitting a 52-week low?
Should investors buy Natco Pharma Ltd stocks when they hit a 52-week low?
How often should investors monitor the 52-week low of Natco Pharma Ltd stocks?
How can an investor assess the risk of buying Natco Pharma Ltd stock at their 52-week low?
Should investors consider the overall market trend when evaluating Natco Pharma Ltd stocks at their 52-week low?
Unlimited trading at just
Rs. 199*